Bratislava wants exemption from EU plan to halt Russian oil and gas imports if bloc wants its support for new sanctions ...

Suven Life Sciences announced that the first patient has been randomized in its Phase-2b clinical trial evaluating Ropanicant, a novel oral α4β2 nicotinic acetylcholine receptor (nAChR) antagonist, ...

The SOFC unit, to be manufactured at Eld Energy’s facility in Bergen, Norway, is scheduled for installation in 2026. Modec ...

Anixa Biosciences' breast cancer vaccine elicited targeted immune responses in 70% of patients. Click here to read an ...

A lot of salary cap resources have been sunk into the defensive line. DeForest Buckner's cap hit of $26.6 million is the ...

BI 1815368, a potential oral treatment to improve vision in patients with diabetic macular edema, is being investigated in a ...

In this video, Ashkan M. Abbey, MD, FASRS, FAAO, of Texas Retina Associates, discusses his presentation at Clinical Trials at the Summit on the use of EyePoint’s Duravyu in neovascular age-related ...

The molecule, developed in collaboration with Massachusetts-based Kailera Therapeutics, is headed for a new drug application ...

By approving a preliminary and final plat for phase II of the Warsaw Technology Park, along with a separate resolution Monday ...

The Nasdaq-100 index plunged into bear market territory in April, but it has since recovered its losses and entered a new ...

Ultragenyx's high burn rate, costly R&D, and recent setbacks increase dilution risk, impacting future profitability. Learn ...

Crypto analysts forecast Bitcoin to go above $130,000 before there is any meaningful market correction as institutional ...